P25273 AF NFT

Kunitz-type trypsin inhibitor KTI2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeic62hptmbhxpxvgqr76tkhdnameb3v7qlhh63kt3sufhhfbpxqbeu/metadata.json
IPFS of structure file: 
bafybeiewyvmfy2wdkyxswjhuswvupueicjdcosbav2yu3sp6t3k3hoimym/AF-P25273-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x603786131b429eaC7e663e5851C902F5dCB72B70
First NFT owner address (bech32): 
genesis1vqmcvycmg202clnx8ev9rjgz7hwtw2msrd9yvr
Current NFT ID #205976 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
205976
Accession (UniProt):
P25273
Name::
Kunitz-type trypsin inhibitor KTI2
Experimental Method:
Predicted structure
Sequence source:
GLYCINE MAX

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P25273 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P25273|KTI2_SOYBN Kunitz-type trypsin inhibitor KTI2 OS=Glycine max OX=3847 GN=KTI2 PE=2 SV=1 MKSTIFFALFLVCAFTISYLPSATAQFVLDTDDDPLQNGGTYYMLPVMRGKSGGIEGNSTGKEICPLTVVQSPNKHNKGIGLVFKSPLHALFIAERYPLSIKFDSFAVIPLCGVMPTKWAIVEREGLQAVTLAARDTVDGWFNIERVSREYNDYYKLVFCPQEAEDNKCEDIGIQIDNDGIRRLVLSKNKPLVVEFQKFRSSTA